皮肤冠状动脉干预结果的性别差异在患有缺血性心脏病的患者中
Antonia Sambola1,2,3, Bruno García Del Blanco1,2,3, Vijay Kunadian4,5
1Department of Cardiology, Hospital Universitari Vall d'Hebron, Universitat Autònoma Bellaterra, Spain.
European cardiology
|July 17, 2023
概括
患有缺血性心脏病的女性比男性更少接受皮肤冠状动脉干预 (PCI). 本综述研究了PCI结果中的性别差异,考虑了患者因素和临床情景.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 缺血性心脏病是全球主要的死亡原因.
- 与男性相比,女性接受指导方针推的穿皮冠状动脉干预 (PCI) 的可能性较小.
- 在考虑到临床特征后,PCI结果的性别差异存在不确定性.
研究的目的:
- 审查最近的证据,比较男性和女性之间的PCI结果.
- 在各种临床情景 (ACS,稳定性胸痛,复杂病变) 中分析PCI结果的性别差异.
- 评估当前指南中对性别的考虑,并为女性患者提供临床管理见解.
主要方法:
- 系统审查已发表的文献,比较男性和女性PCI结果.
- 专注于调整临床特征和并发症的研究.
- 分析特定情景的结果,如急性冠状动脉综合征和复杂的冠状动脉干预.
主要成果:
- 接受PCI的女性往往具有更高的并发症负担,并且比男性年长.
- 对于接受PCI的女性来说,未经调整的结果往往更差.
- 在风险调整后,关于性别特异性结果的证据仍在发展,需要进一步调查.
结论:
- 穿皮冠状动脉干预 (PCI) 结果的性别差异仍然存在,需要进一步研究.
- 对于接受PCI的女性患者,当代的治疗策略需要仔细考虑性别特异性因素.
- 准则还应进一步解决心血管保健和干预程序中的性别特异性细微差别.
相关概念视频
Acute Coronary Syndrome III: Diagnostic Studies
10
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
10
Acute Coronary Syndrome I: Introduction
31
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
31
Coronary Artery Disease V: Interprofessional Care
10
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
10
Ischemic Heart Disease: Overview
1.3K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Cardiac Catheterization I: Pre-Procedure Overview
69
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
69
Acute Coronary Syndrome IV: Interprofessional Care
12
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
12


